Edgen Stock·Sep 14 2025, 00:53戻る
戻る
Large-Cap Pharmaceutical Sector Navigates Regulatory Headwinds Amidst Aggressive M&A and Pipeline Innovation
Edgen Stock·Sep 14 2025, 00:53
[1] Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novartis, Pfizer and Bayer (https://finance.yahoo.com/news/zacks-industry ...)[2] Is biopharma dealmaking getting hot again? - PharmaVoice (https://vertexaisearch.cloud.google.com/groun ...)[3] Pfizer's Comeback Accelerates (NYSE:PFE) | Seeking Alpha (https://vertexaisearch.cloud.google.com/groun ...)